|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Revenue | ||
| Cost of revenue | ||
| Gross profit | ||
| Selling, general and administrative expenses | ||
| Loss on Impairment | ||
| Loss from operations | ||
| Other income (expenses) | ||
| Interest income | ||
| Interest expense | ||
| ELOC facility transaction expenses | ||
| Changes in fair value of derivative liability (see Note 8) | ||
| Total other income (expenses) | ||
| Loss before income taxes | ||
| Provision (benefit) for income taxes | ||
| Net loss | ||
| Weighted average common shares outstanding - basic | ||
| Weighted average common shares outstanding - diluted | ||
| Net loss per common share - basic | ||
| Net loss per common share - diluted |
Loading...
